Dupont Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,228
| Closed | -$211K | – | 749 |
|
|
2022
Q4 | $211K | Sell |
13,228
-27,166
| -67% | -$432K | 0.01% | 777 |
|
|
2022
Q3 | $661K | Buy |
40,394
+20,011
| +98% | +$327K | 0.04% | 541 |
|
|
2022
Q2 | $287K | Hold |
20,383
| – | – | 0.01% | 871 |
|
|
2022
Q1 | $494K | Sell |
20,383
-1,803
| -8% | -$43.7K | 0.02% | 752 |
|
|
2021
Q4 | $518K | Buy |
22,186
+6,671
| +43% | +$156K | 0.02% | 760 |
|
|
2021
Q3 | $258K | Buy |
+15,515
| New | +$258K | 0.01% | 1124 |
|
|
2021
Q2 | – | Sell |
-3,188
| Closed | -$82K | – | 1717 |
|
|
2021
Q1 | $82K | Sell |
3,188
-7,181
| -69% | -$185K | ﹤0.01% | 1379 |
|
|
2020
Q4 | $554K | Buy |
10,369
+2,853
| +38% | +$152K | 0.01% | 802 |
|
|
2020
Q3 | $310K | Buy |
7,516
+4,454
| +145% | +$184K | 0.01% | 958 |
|
|
2020
Q2 | $148K | Sell |
3,062
-16,040
| -84% | -$775K | ﹤0.01% | 1196 |
|
|
2020
Q1 | $807K | Sell |
19,102
-2,404
| -11% | -$102K | 0.02% | 515 |
|
|
2019
Q4 | $920K | Buy |
21,506
+3,685
| +21% | +$158K | 0.02% | 600 |
|
|
2019
Q3 | $641K | Sell |
17,821
-1,911
| -10% | -$68.7K | 0.01% | 674 |
|
|
2019
Q2 | $527K | Buy |
+19,732
| New | +$527K | 0.01% | 757 |
|